✨ Unlock Data Exports And Disclosure Access.Start Your 30-Day Free Trial Today →

Innovent Biologics Inc

Common Name
Innovent Biologics
Country
China (Mainland)
Sector
Healthcare
Industry
Biotechnology
Employees
5,659
Ticker
1801
Exchange
Hong Kong Exchanges and Clearing Limited
Description
Innovent Biologics Inc. engages in the research, development, manufacture, and sale of biologic therapies, primarily focusing on oncology, autoimmune, metabolic, and other major diseases. As a pharmac...

Innovent Biologics's Revenues Data

Explore Innovent Biologics's total revenue by fiscal year, normalized to USD alongside the as-reported original currency value.

Metric2025202420232022-2019
Total Revenue(millions of USD)
1,863a
CN¥13,042 million
1,291a
CN¥9,422 million
873a
CN¥6,206 million
Usage Policy

You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"

Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.

Verified Sources Behind Innovent Biologics’s Revenues Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.

a. Innovent Biologics's Annual Report 2025